Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06157151
Title PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Precigen, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arkansas for Medical Sciences ACTIVE_NOT_RECRUITING Little Rock Arkansas 72205 United States Details
National Institute of Health RECRUITING Bethesda Maryland 20892 United States Details
University of Washington ACTIVE_NOT_RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field